This article was originally published in The Gray Sheet
Beckman Coulter: Proceeds of a planned $400 mil. private placement of senior notes will be used to prepay a portion of its existing bank borrowings - incurred to fund the combination of Beckman Instruments and Coulter Corporation in October 1997 - and finance a tender offer to repurchase its $100 mil. in 7.05% debentures due June 1, 2026. The offering, which is anticipated to close on March 4, consists of $160 mil. in senior notes due March 4, 2003, with an annual interest rate of 7.1% and $240 mil. in senior notes due March 4, 2008, with an annual interest rate of 7.45%...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.